These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 4639018

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The catabolism of Tay-Sachs ganglioside in rat brain lysosomes.
    Tallman JF, Brady RO.
    J Biol Chem; 1972 Dec 10; 247(23):7570-5. PubMed ID: 4636324
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Diagnosis of Tay-Sachs disease using [3H]N-acetylneuraminic acid labelled GM2 ganglioside as substrate.
    Poulos A, Holding J, Carey WF.
    Clin Chim Acta; 1982 Apr 23; 120(3):331-40. PubMed ID: 6210469
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Preparation of radioactive Tay-Sachs ganglioside labeled in the sialic acid moiety.
    Kolodny EH, Brady RO, Quirk JM, Kanfer JN.
    J Lipid Res; 1970 Mar 23; 11(2):144-9. PubMed ID: 5418476
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Demonstration of an alteration of ganglioside metabolism in Tay-Sachs disease.
    Kolodny EH, Brady RO, Volk BW.
    Biochem Biophys Res Commun; 1969 Oct 22; 37(3):526-31. PubMed ID: 5388728
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Enzyme alterations and lipid storage in three variants of Tay-Sachs disease.
    Sandhoff K, Harzer K, Wässle W, Jatzkewitz H.
    J Neurochem; 1971 Dec 22; 18(12):2469-89. PubMed ID: 5135907
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Absence of hexosaminidase A and B in a normal adult.
    Dreyfus JC, Poenaru L, Svennerholm L.
    N Engl J Med; 1975 Jan 09; 292(2):61-3. PubMed ID: 1109441
    [Abstract] [Full Text] [Related]

  • 14. Tay-Sachs disease and normal cerebellar cells in culture: elevated levels of lysosomal enzymes in Tay-Sachs disease cells.
    Hoffman LM, Brooks SE, Schneck L.
    J Neurosci Res; 1982 Jan 09; 8(1):49-55. PubMed ID: 6816949
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Subcellular fractions from Tay-Sachs brains: ganglioside, lipid, and protein composition and hexosaminidase activities.
    Kornguth S, Wannamaker B, Kolodny E, Geison R, Scott G, O'Brien JF.
    J Neurol Sci; 1974 Jul 09; 22(3):383-406. PubMed ID: 4857837
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The Tay-Sachs disease fibroblast model: failure to respond to exogenous hexosaminidase A.
    Schneck L, Amsterdam D, Brooks SE, Rosenthal AL, Volk BW.
    Pediatrics; 1973 Aug 09; 52(2):221-6. PubMed ID: 4721444
    [No Abstract] [Full Text] [Related]

  • 20. Asialo GM-ganglioside in brain fetal Tay-Sachs disease.
    Schneck L, Pinkett B, Volk BW.
    J Neurochem; 1975 Jan 09; 24(1):183-4. PubMed ID: 1110360
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.